Next-Generation Probiotics Offered by Creative Biolabs for Disease Research
New York, USA – December 27, 2023 – Major depressive disorder (MDD), a prevalent mental health condition affecting millions globally, has spurred scientific exploration into alternative therapeutic avenues. The gut-brain axis, a bidirectional communication system between the gastrointestinal tract and the central nervous system, has gained significant attention in recent years. Emerging research suggests that the composition of gut microbiota plays a pivotal role in mental health, including conditions like MDD.
In a bid to expedite research in MDD, Creative Biolabs is dedicated to offering process development and optimization for next-generation probiotics (NGPs). These NGPs target various diseases associated with the human microbiome, encompassing strains like Bifidobacterium breve, Bifidobacterium longum, and Pediococcus acidilactici.
“Research indicates that Bifidobacterium breve may influence mood regulation by contributing to neurotransmitter production,” stated an expert at Creative Biolabs. The company provides comprehensive drug discovery services for B. breve, offering solutions ranging from strain selection to administration methods to support global research in MDD.
Bifidobacterium longum, another crucial probiotic strain, has shown potential in modulating the immune system and reducing inflammation. Creative Biolabs’ proprietary B. longum strain is designed to maximize these beneficial properties, opening up avenues for research into the inflammatory aspects of major depressive disorder.
Pediococcus acidilactici, a less explored probiotic strain, is gaining attention for its potential anti-inflammatory and immunomodulatory effects. Creative Biolabs’ P. acidilactici strain is poised to contribute to a deeper understanding of the gut-brain axis and its role in mental health.
The leading scientist at Creative Biolabs, expressed enthusiasm about the potential impact of these next-generation probiotics. “Our team has worked tirelessly to develop probiotic strains that go beyond conventional applications. The inclusion of Bifidobacterium breve, Bifidobacterium longum, and Pediococcus acidilactici in our portfolio reflects our commitment to advancing scientific knowledge and paving the way for innovative therapeutic strategies.”
Visit https://live-biotherapeutic.creative-biolabs.com to find out a full range of next-generation probiotics offered by Creative Biolabs.
About Creative Biolabs
Creative Biolabs, a distinguished Contract Research Organization (CRO), specializes in live biotherapeutic drug discovery. Focused on next-generation probiotics, the company has systematically honed its platform with cutting-edge technologies and a seasoned scientific staff. With numerous successfully completed projects, Creative Biolabs has garnered the satisfaction of hundreds of clients, solidifying its standing in the field.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://live-biotherapeutic.creative-biolabs.com
